The life sciences industry is continuing to grow, which has led to a boom in available jobs without a similar increase in qualified graduates. We are therefore seeing now a life science talent shortage in many parts of the world. While this is great news for scientists, with many new job...
Read more
In today's fast-paced scientific industry, digitization and automation of laboratories have become crucial for achieving cost-effective innovation. dsm-firmenich, a multinational company specializing in health, nutrition, and beauty, recognized the need to accelerate experimentation and capture...
Read more
We are excited to announce our partnership with Revvity Signals, which begins with integrating our voice-powered digital lab assistant with their Signals™ Notebook, a leading cloud native Electronic Lab Notebook (ELN) used in the pharmaceutical industry. Researchers can now use voice to capture...
Read more
It’s all over the news: like many other tech companies, Amazon is laying off a thousand of employees and most of the eliminated jobs are from Alexa’s division. The voice assistant has been operating at a $5 billion-per-year loss and from now on will be...
Read more
Today, Royal DSM N.V., a global company specializing in health, nutrition, and sustainable living, and LabTwin GmbH, the leading voice and AI-powered digital lab assistant, announce a multi-year license and collaboration agreement. DSM will apply the newly acquired technology in several of their...
Read more
In this era of data-driven decisions, harnessing predictive machine learning models is the ultimate goal of most organizations. To build such models, high-quality data and metadata must be captured at the point of experimentation. The challenge is to enable seamless data capture for scientists...
Read more
The pharmaceutical industry is undergoing a digital revolution to improve its R&D efficiency and leverage the power of big data to accelerate the time-to-market.
Read more
Pharmaceutical companies are striving to harness the power of Artificial Intelligence (AI) to turn rich data resources into strategic assets.
Read more
Covestro, a world leading manufacturer of high-tech polymers, serves a range of industries, including electrical and electronics, automotive, construction and health. To remain at the forefront of premium polymer supply, Covestro is implementing a digital innovation program across core areas. The...
Read more
Many pharmaceutical R&D labs are embracing automation to increase throughput while lowering error rates. Automation takes care of mundane, repetitive tasks, allowing scientists more time to work on the challenging and rewarding parts of research – such as planning experiments, analyzing data and...
Read more
Digital transformation promises to lower R&D costs, improve productivity and accelerate product development. Mobile technologies have helped digitalize a number of industries and are now being adopted in R&D labs within the life science and materials science sectors.
Read more
Electronic lab notebooks (ELNs) have been at the forefront of pharmaceutical digitalization. This technology promised to replace paper notebooks with a digital system that was easy, flexible and secure. However, many labs adopted ELNs only to find that they were static and...
Read more
A Senior Research Scientist in the In Vivo Cardiac Regeneration group at a Top Pharma Company recently used LabTwin and shared her experience. She collaborates with other teams to study heart regeneration following myocardial infarction in mice and pigs. More specifically, she performs complex...
Read more
Recent progresses in AI-powered drug discovery bring a considerable number of potential drug candidates to the primary assay stage. However, only 10% will go through to clinical trials. It is therefore essential to quickly and accurately screen drug candidates, discard toxic or ineffective...
Read more
Everyone expects medicines to be safe and effective. Therefore, regulatory authorities require that drug manufacturing processes follow current Good Manufacturing Practice (cGMP). Microbiological testing commonly occurs at several stages of drug development to ensure that products are not...
Read more
Bringing a new drug on the market is a long and expensive process. Biopharmaceutical companies spend around $1 billion in R&D per therapeutic product and the recent pandemics have highlighted the necessity of accelerating the deployment of new targeted drugs.
Read more
